Message from the CEO
“At Benten Biotech, we believe that innovation doesn’t begin in the laboratory, but rather in each company’s strategy. Our mission is to support those who lead biologics and IVD laboratories in transforming complex challenges into protectable, validated, and scalable solutions.
We act as allies, not as third parties. With the agility of a biotech company and the commitment of a strategic partner.”
Esteban Guerra CEO - Benten Biotech
We are science with purpose
For years, we’ve supported veterinary biological laboratories in different countries, advising on production, formulation and efficacy testing in accordance with the American and/or European Pharmacopoeia.
That experience allowed us to see a pattern. Companies needed to:
- Accelerate their R&D
- Incorporate technology
- Align their projects with their business objectives
- Transform scientific knowledge into protectable assets
But there was no CRO specializing in veterinary biologics capable of offering that integration in Latin America.
Thus Benten Biotech was born, to fill that gap with a clear proposal: to design and implement innovative developments that not only solve a technical problem, but also strengthen the competitiveness of each company through viable, scalable and patentable solutions.
We don’t just execute tasks. We get involved as strategic partners in innovation. We align science, intellectual property, and commercial strategy into a single action plan, adapted to the reality and projection of each client.
Results that speak for themselves
- +90% of our projects meet their objectives on time and budget.
- +20 innovation projects and R+D+i services completed to date.
- +12 international clients operating in 9 countries.
- +1M more than 1 million dollars of public funds executed in co-financing.
- +3M more than 3 million dollars of private funds executed.
- 18 months average duration of R&D&I projects up to the preclinical studies stage.
We don’t just do science.
We build solutions ready to compete.
Through our own platforms and cutting-edge technologies, we design innovation roadmaps aligned with business objectives, prioritizing focus, speed, and value creation.
Every development we undertake is designed to be viable, patentable, and with real potential for technology transfer and commercial projection.
We transform scientific complexity into a sustainable competitive advantage.
-
New generation recombinant vaccines
Learn more -
Antibodies therapy TRL 4-5
Learn more -
Immunoassays on the market
Learn more
What they think of us
-
“In our experience as a global company, Benten Biotech has proven to be a reliable organization, with a high level of scientific knowledge and a clear focus on innovation. Their support has been fundamental in the design and development of products, and in the implementation of cutting-edge analytical techniques that meet the highest quality standards. They are distinguished not only by their technical capacity, but also by their flexibility and professionalism. Thanks to this level of commitment, Benten Biotech has established itself as a partner that boosts our internal capabilities and allows us to advance more quickly in a highly competitive environment.”
Daniel Diaz CMO Global Director - Valo BioMedia -
“The interaction with Benten Biotech has been extremely valuable professionally. Their team has a solid scientific background, commitment, and a collaborative attitude that has enriched every stage of our joint development. Their strategic focus and technical maturity have contributed to achieving significant and reliable advances, reflecting a serious and effective collaboration.”
Pablo Halperin Executive Manager of R&D - CDV -
“Benten Biotech has been a consultant for our veterinary vaccine company for several years, and we are very grateful for the quality of their technical service, their versatility, and their timely response. In every case, we have received excellent customer service, evidenced by their availability for remote technical follow-up and on-site visits, which have contributed to successful technology transfers in the various projects we have undertaken.”
Zulma Suárez R&D Director - VECOL S.A. -
“When it comes to finding solutions and working quickly, Benten has delivered. In a short time, the project team demonstrated strong proof-of-concept for assays based on their camelid nanobodies, then quickly pursued optimization. When one of the assay models did not perform as expected, the Benten team objectively evaluated their data, took critical comments seriously, and ultimately produced a better model. Communication with Benten was facile and timely, they were extremely patient, and they were consistently eager to work with us to develop the best solution for our needs. I am personally quite impressed by my experience with Benten Biotech and will strongly consider them in the future.”
Jeremy Rush SR AD - Global animal health company (USA)
Can you relate?
If you’re investing in R&D without clear results, or you want to accelerate the development of a vaccine, test, or technology, we can help you move forward with strategy, speed, and protection.
Schedule a 30-minute call and find out if your project is viable, scalable, and patentable.
Innovating with purpose starts with a conversation.
